Lead researcher
Dr Michaela Waibel, Prof Ricky Johnstone, Prof John Seymour
Institution
Cancer Therapeutics Program, Peter MacCallum Cancer Centre
Years funded
2015-2017
Our
research focuses on novel combination therapies for haematological cancers
driven by activation of particular cell survival pathways. We investigate how
certain genetic changes promote the survival of cancer cells, and how these
cancer cells become resistant to drug treatment. This will allow us to develop
novel potent combination therapies for the treatment of acute leukaemia and
myeloproliferative neoplasms, and to overcome drug-resistance to improve the
outcomes for patients.
Funding Body
Cancer Council Research Grant
Funding
$99,805 per annum